Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 2002, 62 (1): 65–74. PMID 12065756. doi:10.1124/mol.62.1.65.
Harrison CA, Gray PC, Koerber SC, Fischer W, Vale W. Identification of a functional binding site for activin on the type I receptor ALK4. J. Biol. Chem. 2003, 278 (23): 21129–35. PMID 12665502. doi:10.1074/jbc.M302015200.
Lebrun JJ, Takabe K, Chen Y, Vale W. Roles of pathway-specific and inhibitory Smads in activin receptor signaling. Mol. Endocrinol. January 1999, 13 (1): 15–23. PMID 9892009. doi:10.1210/mend.13.1.0218.
De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors. Exp. Cell Res. May 1996, 224 (2): 323–34. PMID 8612709. doi:10.1006/excr.1996.0142.
Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 2002, 62 (1): 65–74. PMID 12065756. doi:10.1124/mol.62.1.65.
Harrison CA, Gray PC, Koerber SC, Fischer W, Vale W. Identification of a functional binding site for activin on the type I receptor ALK4. J. Biol. Chem. 2003, 278 (23): 21129–35. PMID 12665502. doi:10.1074/jbc.M302015200.
Lebrun JJ, Takabe K, Chen Y, Vale W. Roles of pathway-specific and inhibitory Smads in activin receptor signaling. Mol. Endocrinol. January 1999, 13 (1): 15–23. PMID 9892009. doi:10.1210/mend.13.1.0218.
De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors. Exp. Cell Res. May 1996, 224 (2): 323–34. PMID 8612709. doi:10.1006/excr.1996.0142.